4 resultaten gevonden

Doctoraten 2024 | Farmaceutische, Biomedische en Diergeneeskundige Wetenschappen | Universiteit Antwerpen

Farmaceutische, Biomedische en Diergeneeskundige Wetenschappen Doctoraten 2024 Doctoraten 2024 Analyse van gerichte therapie effecten in ROS1+ NSCLC met behulp van genomisch gemanipuleerde cellijnen afkomstig uit patiëntenmateriaal - Marc Terrones Bernat (9/12/2024) Marc Terrones Bernat 9 december …

https://www.uantwerpen.be/nl/overuantwerpen/faculteiten/faculteit-fbd/onderzoek/doctoraatsverdedigingen/departement-biomedische-wetenschappen/doctoraten-2024/

PhD Defences 2024 | Pharmaceutical, Biomedical and Veterinary Sciences | University of Antwerp

Pharmaceutical, Biomedical and Veterinary Sciences PhD Defences 2024 PhD Defences 2024 Profiling targeted therapy responses in ROS1+ non-small cell lung cancer using genomically engineered patient-derived cell lines - Marc Terrones Bernat (9/12/2024) Marc Terrones Bernat 9 December 2024, 4 pm - 6 pm…

https://www.uantwerpen.be/en/about-uantwerp/faculties/fbd/research/public-defences/department-of-biomedical-sciences/defences-2024/

Research Marc Peeters | Marc Peeters | University of Antwerp

Marc Peeters full professor Research Marc Peeters Research team Center for Oncological Research (CORE) Expertise My expertise is in the field of oncology or cancer research. It is mainly focused on clinical translational research. This domain is very broad and ranges from bio-research to clinical st…

https://www.uantwerpen.be/en/staff/marc-peeters/research/

Projects | Center for Oncological Research | University of Antwerp

Center for Oncological Research search menu search content Projects Ongoing projects Tackling delayed diagnosis and therapy resistance in pleural mesothelioma: identification of biomarkers and molecular therapeutic targets. 01/11/2024 - 31/10/2026 Abstract Pleural mesothelioma (PM) is a rare and hig…

https://www.uantwerpen.be/en/research-groups/core/research-/projects/